Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Provided By GlobeNewswire

Last update: Nov 12, 2024

Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK^® in autoimmune diseases